Quick Answer
Cellebrite DI Ltd. reported Cash and Equivalents of $124.46 million for fiscal year 2025.
Cellebrite DI Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $124.46M | -35.1% |
| 2024 | $191.66M | +1.1% |
| 2023 | $189.52M | +116.2% |
| 2022 | $87.64M | — |
- Cellebrite DI Ltd. showed a decrease of -35.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, Cellebrite DI Ltd.’s cash and equivalents has grown by 42.0% (from $87.64 million to $124.46 million).
- The most recent figure is from Cellebrite DI Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: